Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,500.00
-95.00 (-3.66%)
Jun 11, 2026, 12:45 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 91.28 billion as of June 10, 2026. Its market cap has decreased by -45.71% in one year.
Market Cap
91.28B
Enterprise Value
-240.30B
Revenue
14.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,500.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 91.28B, a decrease of -66.08%. That is a compound annual growth rate of -7.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 91.28B | -31.71% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.03T |
| Celltrion | 35.08T |
| ALTEOGEN | 17.79T |
| Samsung Epis Holdings | 11.05T |
| T&R Biofab | 102.51B |
| ENCell | 101.32B |
| Amicogen | 99.20B |
| HANDOK | 98.73B |